drugset / Trial / NCT00748371

Loss of Effect of Aspirin on Platelet Aggregation During Chronic Administration

NCT00748371 ↗

Phase 4 Terminated 51 enrolled Vanderbilt University
RandomizedParallel-groupDouble-blindBasic science

Summary

Aspirin has shown to be beneficial to some patients with certain diseases such as coronary artery disease or stroke. We are investigating how aspirin works on regulating platelets and thromboxane over time at different doses. We hope to find the best dose of aspirin and/or other medications to help people who are at risk for heart attack or stroke.

Timeline

Start
2004-06
Primary completion
2011-02
Completion
2011-02

Outcome

Outcome not reported

Stopped (Business): “Funding issue”

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule 40 mg Oral
Subject Aspirin Small molecule 1300 mg Oral